Despite available pharmacological and interventional therapies, refractory angina is a
common and disabling clinical condition, and a major public health problem, which affects …

Background Symptomatic relief is the primary goal of percutaneous coronary intervention
(PCI) in stable angina and is commonly observed clinically. However, there is no evidence …

Although non-invasive perfusion and viability imaging often provide the gateway to coronary
revascularisation, current non-invasive imaging methods only report the surrogate markers …

Purpose Patient-reported outcome measures (PROMs) capture health information from the
patient's perspective that can be used when weighing up benefits, risks and costs of …

Background: Recently, the therapeutic benefits of percutaneous coronary intervention (PCI)
have been challenged in patients with stable coronary artery disease (SCD). Objectives: The …

Cardiovascular medicine is one of the specialties that has relied most heavily on evidence
from randomised clinical trials in determining best practice for the management of common …

Background In patients with ischaemic left ventricular dysfunction, coronary artery bypass
surgery (CABG) may decrease mortality, but it is not known whether CABG improves …

Introduction: Traditional and current perception for benefit of percutaneous coronary
intervention (PCI) is that patients with stable angina will obtain symptom relief as well as …

Stable coronary artery disease (CAD) is characterized by presence of stress-induced
myocardial ischemia, in the myocardial territory supplied by a flow-limiting stenosis …

Most published trials fail to show a benefit from coronary stenting in patients with stable
obstructive coronary artery disease. However, stent technology has evolved significantly in …